# Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease

> **NCT05162508** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2000 (estimated)

## Conditions studied

- SARS-CoV2 Infection
- COVID-19 Acute Respiratory Distress Syndrome
- Mutation

## Interventions

- **OTHER:** Nasopharyngeal swab

## Key facts

- **NCT ID:** NCT05162508
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-16
- **Primary completion:** 2026-01-16
- **Final completion:** 2026-01-16
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05162508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05162508, "Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05162508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*